A heart transplantation. 5. Postoperative medical aspects.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001145:Arrhythmias, Cardiac / Q000209:etiology; D001315:Australia; D001379:Azathioprine / Q000008:administration & dosage; D001623:Betamethasone / Q000008:administration & dosage; D001794:Blood Pressure; D001799:Blood Sedimentation; D004077:Digoxin / Q000008:administration & dosage; D004487:Edema / Q000209:etiology; D004562:Electrocardiography; D005665:Furosemide / Q000008:administration & dosage; D006029:Glycosuria / Q000209:etiology; D006326:Heart Auscultation; D016027:Heart Transplantation; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D006884:Hydroxybutyrate Dehydrogenase / Q000097:blood; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007239:Infections / Q000209:etiology; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007362:Intensive Care Units; D007545:Isoproterenol / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012119:Respiration; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014680:Veins
D000900:Anti-Bacterial Agents; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D004077:Digoxin; D005665:Furosemide; D001623:Betamethasone; D006884:Hydroxybutyrate Dehydrogenase; D007545:Isoproterenol; D001379:Azathioprine; D006854:Hydrocortisone